Symptom burden and oxygen therapy predict poorer quality of life in pulmonary hypertension

J. Yorke (Manchester, United Kingdom)

Source: International Congress 2017 – Delivering person-centred care across the spectrum of respiratory nursing
Session: Delivering person-centred care across the spectrum of respiratory nursing
Session type: Oral Presentation
Number: 3239

Congress or journal article abstractWebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
J. Yorke (Manchester, United Kingdom). Symptom burden and oxygen therapy predict poorer quality of life in pulmonary hypertension. 3239

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Impact of insomnia on exercise capacity and quality of life in patients with pulmonary arterial hypertension
Source: International Congress 2017 – PAH and CTEPH
Year: 2017


Impact of Sars-CoV-2-Pandemic on mental disorders and quality of life in patients with pulmonary arteriaI hypertension
Source: Virtual Congress 2021 – Pulmonary hypertension in the COVID-19 pandemic and beyond
Year: 2021

Relationship of quality of life and life expectancy with tolerance to physical exercises and cardio respiratory parameters in patients with pulmonary arterial hypertension
Source: Annual Congress 2013 –Novel biomarkers and old parameters in clinical management of lung diseases
Year: 2013

Relation of the novel pulmonary hypertension emPHasis10 quality of life score to markers of disease severity
Source: International Congress 2015 – Pulmonary hypertension: management
Year: 2015


Negative impacts of unreported COPD exacerbations on health-related quality of life at 1 year
Source: Eur Respir J 2010; 35: 1022-1030
Year: 2010



emPHasis-10: development of a health-related quality of life measure in pulmonary hypertension
Source: Eur Respir J 2014; 43: 1106-1113
Year: 2014



Anxiety and depression are highly prevalent in pulmonary hypertension and might improve with target therapy
Source: International Congress 2015 – Pulmonary hypertension: novel clinical insights
Year: 2015


EmPHasis-10 is associated with clinical outcome measures in pulmonary hypertension
Source: Annual Congress 2013 –Pulmonary circulation: clinical diagnosis, imaging, biomarkers and treatment
Year: 2013


Measurement of quality of life in pulmonary hypertension and its significance
Source: Eur Respir J 2006 Oct 01;28(4):808-815
Year: 2006



Dyspnea sensation and health-related quality predict exacerbations, hospitalizations and mortality in patients with chronic respiratory failure receiving long-term oxygen therapy
Source: Eur Respir J 2006; 28: Suppl. 50, 519s
Year: 2006

Pulmonary arterial hypertension: the burden of disease and impact on quality of life
Source: Eur Respir Rev 2015; 24: 621-629
Year: 2015



Pulmonary rehabilitation outcome: quality of life (QoL) and COPD severity
Source: Eur Respir J 2004; 24: Suppl. 48, 633s
Year: 2004

Impact of riociguat on health-related quality of life (HRQoL) in patients with pulmonary arterial hypertension (PAH)
Source: Annual Congress 2013 –Pulmonary circulation: clinical science and treatment
Year: 2013


Detection of quality of life with COPD assessment test in chronic obstructive pulmonary disease and effect of dyspnea on disease-specific quality of life in these patients
Source: Annual Congress 2012 - Methodology in epidemiologic research
Year: 2012

Ambulatory oxygen improves quality of life of COPD patients: a randomised controlled study
Source: Eur Respir J 2002; 20: 306-312
Year: 2002



Impact of riociguat on health-related quality of life (HRQoL) in patients with chronic thromboembolic pulmonary hypertension (CTEPH)
Source: Annual Congress 2013 –Pulmonary circulation: clinical science and treatment
Year: 2013


The quality of life evaluation and survival study (QuESS): comorbidities in patients with chronic respiratory failure do not influence status as measured by quality of life questionnaires
Source: Eur Respir J 2001; 18: Suppl. 33, 54s
Year: 2001

Predictors of health-related quality of life in patients with chronic obstructive pulmonary disease
Source: Eur Respir J 2006; 28: Suppl. 50, 66s
Year: 2006

Assessment of quality of life and social and economic impact of the disease in patients with pulmonary arterial hypertension in Germany – Data of the SANTANA-Study
Source: Virtual Congress 2020 – Clinical evaluation, biomarkers and risk assessment of pulmonary hypertension
Year: 2020


Development of a comorbidity index that reflects health-related quality of life in patients with COPD
Source: Annual Congress 2011 - Challenges in chronic disease management: helping individuals with chronic lung disease remain stable
Year: 2011